Company Bausch Health Companies Inc. Toronto S.E.

BHC

CA0717341071

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2026-01-12 EST			5-day change	1st Jan Change
10.39 ^CAD	+0.58%		+1.76%	+9.02%

01-07	Truist Securities Adjusts Price Target on Bausch Health to $8 From $7, Maintains Hold Rating	MT
01-02	Bausch + Lomb Completes Refinancing of Outstanding Term B Loans	MT

Business description: Bausch Health Companies Inc.

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Number of employees: 20,700

Sales by Activity: Bausch Health Companies Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
Bausch + Lomb	-	3.76B	3.77B	4.15B	4.79B
Salix	1.9B	2.07B	2.09B	2.25B	2.33B
International	-	1.17B	988M	1.07B	1.11B
Diversified	1.16B	865M	978M	943M	950M
Ortho Dermatologics Segment	553M	564M	-	-	-
Bausch + Lomb/International	4.41B	-	-	-	-
Solta Medical	-	-	300M	347M	440M

See all business segments

Geographical breakdown of sales: Bausch Health Companies Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
U.S. and Puerto Rico	4.79B	4.89B	4.84B	5.19B	5.77B
Other	1.01B	986M	887M	1.01B	1.08B
China	341M	490M	413M	441M	496M
Canada	331M	343M	351M	366M	402M
Poland	238M	280M	278M	319M	350M
Mexico	225M	256M	276M	322M	315M
France	179M	208M	203M	214M	230M
Japan	226M	230M	200M	194M	188M
Russia	137M	160M	181M	148M	161M
Germany	144M	154M	147M	152M	159M
South Korea	-	-	77M	93M	146M
United Kingdom	86M	116M	115M	125M	135M
Spain	78M	88M	84M	92M	99M
Italy	-	80M	76M	86M	94M
Egypt	243M	156M	-	-	-

See all geographic segments

Executive Committee: Bausch Health Companies Inc.

Manager	Title	Age	Since
Thomas Appio CEO	Chief Executive Officer	63	2022-05-09
Jean-Jacques Charhon DFI	Director of Finance/CFO	60	2024-08-18
Mirza Dautbegovic COO	Chief Operating Officer	-	-
Steven H. Lee AUD	Comptroller/Controller/Auditor	56	2025-07-13
Aimee Lenar PRN	Corporate Officer/Principal	-	2024-07-14

See BAUSCH HEALTH COMPANIES INC. governance

Composition of the Board of Directors: Bausch Health Companies Inc.

Director	Title	Age	Since
Robert Power CHM	Chairman	69	2022-05-09
Thomas Appio BRD	Director/Board Member	63	2022-05-09
Amy Wechsler BRD	Director/Board Member	56	2016-06-13
Sarah Kavanagh BRD	Director/Board Member	69	2016-07-21
Richard Mulligan BRD	Director/Board Member	72	2022-05-05
John Paulson CHM	Chairman	70	2022-06-22
Christian Garcia BRD	Director/Board Member	63	2024-05-13
Frank Lee BRD	Director/Board Member	58	2024-05-13
Michael Goettler BRD	Director/Board Member	58	2025-07-21
Sandra Leung BRD	Director/Board Member	65	2025-07-21

Composition of the Board of Directors

Shareholders: Bausch Health Companies Inc.

Name	Equities	%	Valuation
Paulson & Co., Inc. 19.77 %	73,255,869	19.77 %	509 M $
Paulson & Co., Inc. 19.1 %	70,755,869	19.1 %	492 M $
Alex Meruelo 9.922 %	36,761,788	9.922 %	255 M $
GoldenTree Asset Management LP 9.401 %	34,833,431	9.401 %	242 M $
Nomura Global Financial Products, Inc. 4.24 %	15,708,085	4.24 %	109 M $

List of BAUSCH HEALTH COMPANIES INC. shareholders

Holdings: Bausch Health Companies Inc.

Name	Equities	%	Valuation
BAUSCH + LOMB CORPORATION 87.65%	310,449,643	87.65%	5 302 M $

Company details: Bausch Health Companies Inc.

Bausch Health Cos., Inc.

2150 St. Elzéar Boulevard West

H7L 4A8, Laval

+514 744 6792

http://www.bauschhealth.com

address Bausch Health Companies Inc.(BHC)

Group companies: Bausch Health Companies Inc.

Name	Category and Sector
Bausch & Lomb India Pvt Ltd. Bausch & Lomb India Pvt Ltd. Manufactures lenses
Bausch & Lomb India Pvt Ltd. Bausch & Lomb India Pvt Ltd. Manufactures lenses
Bausch & Lomb, Inc. Bausch & Lomb, Inc. Manufactures and supplies contact lenses
BAUSCH + LOMB CORPORATION
BAUSCH + LOMB CORPORATION

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ELI LILLY AND COMPANY	+1.64%	+0.06%	+35.14%	+199.94%	952B
JOHNSON & JOHNSON	+2.61%	+1.14%	+47.63%	+19.92%	492B
ABBVIE INC.	-0.02%	-4.04%	+25.62%	+40.00%	389B
ROCHE HOLDING AG	+0.50%	+5.22%	+29.29%	+18.53%	363B
ASTRAZENECA PLC	-0.68%	+5.50%	+30.47%	+23.34%	296B
MERCK & CO., INC.	-1.21%	+2.57%	+10.02%	-1.69%	274B
NOVARTIS AG	-0.18%	+4.92%	+25.39%	+35.33%	273B
NOVO NORDISK A/S	-0.62%	+9.33%	-38.17%	-17.02%	264B
AMGEN INC.	-0.17%	+1.50%	+20.49%	+20.16%	176B
Average	+0.17%	+2.70%	+20.65%	+37.61%	386.57B
Weighted average by Cap.	+0.47%	+1.48%	+25.79%	+68.30%